LIA
ONC

LS Investment Advisors’s BeOne Medicines Ltd ONC Stock Holding History

LS Investment Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-72
Closed -$9K – 1725
2020
Q1 		$9K Sell
72
-448
-86% -$70.1K ﹤0.01% 1568
2019
Q4 		$86K Buy
520
+17
+3% +$2.83K ﹤0.01% 1160
2019
Q3 		$62K Hold
503
– – ﹤0.01% 1239
2019
Q2 		$62K Hold
503
– – ﹤0.01% 1245
2019
Q1 		$66K Hold
503
– – ﹤0.01% 1229
2018
Q4 		$71K Buy
+503
New +$66.7K ﹤0.01% 1169

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

LS Investment Advisors's ONC Position: Q2 2020 in Review

LS Investment Advisors sold out of BeOne Medicines Ltd (ONC) in Q2 2020, closing a stake of 72 shares — an estimated $9K sold.

LS Investment Advisors first reported a position in ONC in Q4 2018 and held it in 6 quarters. The position peaked at $86K in Q4 2019. 220 funds tracked by Wall St. Rank hold ONC as of Q2 2020.

  • LS Investment Advisors reported no remaining BeOne Medicines Ltd position as of Q2 2020 after selling out during the quarter.
  • LS Investment Advisors sold 72 BeOne Medicines Ltd shares in Q2 2020, an estimated $9K.
  • LS Investment Advisors first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 6 quarters.
  • LS Investment Advisors's BeOne Medicines Ltd position peaked at $86K in Q4 2019.
  • 220 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2020.

Based on LS Investment Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.